hycanthone has been researched along with Chronic Illness in 1 studies
Hycanthone: Potentially toxic, but effective antischistosomal agent, it is a metabolite of LUCANTHONE.
hycanthone : A thioxanthen-9-one compound having a hydroxymethyl substituent at the 1-position and a 2-[(diethylamino)ethyl]amino substituent at the 4-position. It was formerly used (particularly as the monomethanesulfonic acid salt) as a schistosomicide for individual or mass treatement of infection with Schistosoma haematobium and S. mansoni, but due to its toxicity and concern about possible carcinogenicity, it has been replaced by other drugs such as praziquantel.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tonelli, E | 1 |
| Penna, FJ | 1 |
| Leão, E | 1 |
| Miranda, D | 1 |
1 other study available for hycanthone and Chronic Illness
| Article | Year |
|---|---|
Acute and early chronic phases of schistosomiasis mansoni in children treated with hycanthone.
Topics: Acute Disease; Adolescent; Child; Chronic Disease; Drug Evaluation; Female; Humans; Hycanthone; Male | 1975 |